The level of ADAMTS13 activity defining a severe deficiency remains uncertain, recent data suggesting that ADAMTS13 activity < 10% alone could be consistent with the diagnosis and treatment of TTP [8]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.